NRC Health Reports 11% Revenue Growth and Margin Expansion in Q3 2026
NRC Health (NRC) reported third-quarter revenue of $38.4 million, marking an 11% year-over-year increase driven by new implementations and contract renewals. The company achieved an adjusted EBITDA of $10.9 million with a 28% margin, reflecting sequential expansion throughout the year. Total Recurring Contract Value (TRCV) rose 9% to $154.1 million as of September 30, 2026. Despite strong momentum and a 60% increase in the sales pipeline, management noted that average deal sizes have decreased due to a shift toward smaller healthcare organizations in recent RFPs. Additionally, market uncertainty following Qualtrics' acquisition of Press Ganey has caused some procurement processes to pause. However, the company is leveraging significant cross-sell opportunities, as approximately 70% of its customer base currently utilizes only one product.
Tickers: $NRC
Topics: Adjusted EBITDA Free Cash Flow Healthcare Solutions Revenue Growth Sales Pipeline